Literature DB >> 1001250

Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis.

F Stormshak, R Leake, N Wertz, J Gorski.   

Abstract

The induction of long-term responses in the uterus following estrogen treatment is discussed, with special reference to DNA synthesis. Immature female rats injected daily with estradiol-17beta or estriol (0.01 to 1 mug) or a combination of the two steroids for one, two or three consecutive days were sacrificed at intervals from 12 to 24 h after the last injection of vehicle or steroid. In vitro incorporation of [3H]thymidine into DNA [14C]leucine into protein, and oxidation of [14C)glucose to 14CO2 were determined. Nuclear-bound estradiol was determined by use of exchange assay or following incubation of intact uteri with 1 X 10(-8)M ([3H]estradiol for 1 h at 37 C. Injection of estriol only partially stimulated DNA synthesis by 18 to 24 h post-treatment. However, injection of estriol followed by injection of estradiol 6 h later resulted in increased DNA synthesis, suggesting that estrogen must be present for up to 6 h to induce subsequent DNA synthesis. Maximal DNA and protein synthesis and oxidation of glucose occurred at 24 h after injection of estradiol (0.1 or 1 mug) but was depressed to control levels by 24 h after the last of three daily injections. Daily injections of 0.01 mug of estradiol resulted in a similar pattern of DNA synthesis, although of lesser magnitude than that observed after injection of 0.1 or 1 mug of estradiol. However, if rats receiving daily injections of 0.01 mug estradiol were challenged with a higher dose of estradiol (1 mug), uterine DNA synthesis was markedly increased. The data suggest that prolonged exposure to estrogen causes uterine cells to become metabolically "refractory" to further estrogen stimulation. Sequential injections of estriol (1 mug) or intermittent injections of estradiol (1 mug) were ineffective in causing this uterine "refractoriness". Receptor binding of estrogen, translocation to the nucleus, and retention of receptor in the nucleus were not affected by sequential estrogen treatment. The accumulation of an inhibitory product is suggested as a possible explanation for this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1001250     DOI: 10.1210/endo-99-6-1501

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  Observations on the origins of plasma membrane in rat deciduoma.

Authors:  W N Yunghans; D J Mooré; N J Karin; D A Werderitsh
Journal:  Cell Tissue Res       Date:  1979-08-03       Impact factor: 5.249

3.  Quantitative trait loci for estrogen-dependent pituitary tumor growth in the rat.

Authors:  D L Wendell; J Gorski
Journal:  Mamm Genome       Date:  1997       Impact factor: 2.957

4.  Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors.

Authors:  R V Lloyd; T D Landefeld; I Maslar; L A Frohman
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

5.  65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness.

Authors:  S Jozan; A M Julia; A Carretie; N Eche; V Maisongrosse; B Fouet; B Marques; J F David
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

6.  Effect of progestins, androgens, estrogens and antiestrogens on 3H-thymidine uptake by human endometrial and endosalpinx cells in vitro.

Authors:  J Neulen; B Wagner; M Runge; M Breckwoldt
Journal:  Arch Gynecol       Date:  1987

7.  Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study.

Authors:  Laura N Vandenberg
Journal:  Dose Response       Date:  2013-10-07       Impact factor: 2.658

8.  Estradiol-17 beta stimulates proliferation of uterine epithelial cells cultured with stromal cells but not cultured separately.

Authors:  K N Astrahantseff; J E Morris
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

Review 9.  From Wingspread to CLARITY: a personal trajectory.

Authors:  Ana M Soto; Cheryl M Schaeberle; Carlos Sonnenschein
Journal:  Nat Rev Endocrinol       Date:  2021-01-29       Impact factor: 47.564

Review 10.  Non-genomic effects of xenoestrogen mixtures.

Authors:  René Viñas; Yow-Jiun Jeng; Cheryl S Watson
Journal:  Int J Environ Res Public Health       Date:  2012-07-31       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.